Development of Ruthenium Complexes with O2-Independent Activity for Photochemotherapy

William Moore,Yujie Sun
2019-01-01
Abstract:By William Moore, Biochemistry Advisor: Yujie Sun Presentation ID: PM_D01 Abstract: Cancer affects millions of people's lives, and though there are many treatments available there is still much that can be done to improve cancer treatment. One of the most popular chemotherapy drugs, cisplatin, is very effective against certain types of cancer cells, but lacks the ability to target only cancer cells. This lack of specificity leads to many unpleasant side effects. Photochemotherapy provides a solution to the problem presented by current chemotherapy agents by activating the drug upon exposure to external stimuli (light). Current photochemotherapy methods rely heavily upon the production of reactive oxygen species (ROS) that subsequently cause oxidative damage to the tumor cell. There are three main issues with using ROS for treatment: first, tumors are often oxygen deficient; second, ROS have a very small diffusion distance of approx.100 nm; third, the activation wavelengths (
What problem does this paper attempt to address?